Lessee, Operating Lease, Liability, to be Paid of BIO-TECHNE Corp from 30 Sep 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
BIO-TECHNE Corp quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 30 Sep 2019 to 31 Dec 2025.
  • BIO-TECHNE Corp Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Dec 2025 was $106,548,000, a 6.2% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $106,548,000 -$6,994,000 -6.2% 31 Dec 2025 10-Q 04 Feb 2026 2026 Q2
Q3 2025 $111,223,000 -$7,367,000 -6.2% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $115,865,000 -$5,129,000 -4.2% 30 Jun 2025 10-K 22 Aug 2025 2025 FY
Q1 2025 $111,169,000 -$16,573,000 -13% 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $113,542,000 -$18,432,000 -14% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q2
Q3 2024 $118,590,000 -$14,962,000 -11% 30 Sep 2024 10-Q 05 Nov 2024 2025 Q1
Q2 2024 $120,994,000 -$8,908,000 -6.9% 30 Jun 2024 10-K 22 Aug 2024 2024 FY
Q1 2024 $127,742,000 -$2,002,000 -1.5% 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $131,974,000 +$21,403,000 +19% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $133,552,000 +$54,234,000 +68% 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $129,902,000 +$47,620,000 +58% 30 Jun 2023 10-K 23 Aug 2023 2023 FY
Q1 2023 $129,744,000 +$51,460,000 +66% 31 Mar 2023 10-Q 08 May 2023 2023 Q3
Q4 2022 $110,571,000 +$30,810,000 +39% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q2
Q3 2022 $79,318,000 -$10,199,000 -11% 30 Sep 2022 10-Q 07 Nov 2022 2023 Q1
Q2 2022 $82,282,000 -$10,509,000 -11% 30 Jun 2022 10-K 24 Aug 2022 2022 FY
Q1 2022 $78,284,000 -$14,457,000 -16% 31 Mar 2022 10-Q 09 May 2022 2022 Q3
Q4 2021 $79,761,000 -$8,583,000 -9.7% 31 Dec 2021 10-Q 07 Feb 2022 2022 Q2
Q3 2021 $89,517,000 -$1,349,000 -1.5% 30 Sep 2021 10-Q 08 Nov 2021 2022 Q1
Q2 2021 $92,791,000 -$229,000 -0.25% 30 Jun 2021 10-K 25 Aug 2021 2021 FY
Q1 2021 $92,741,000 +$13,706,000 +17% 31 Mar 2021 10-Q 07 May 2021 2021 Q3
Q4 2020 $88,344,000 +$7,253,000 +8.9% 31 Dec 2020 10-Q 08 Feb 2021 2021 Q2
Q3 2020 $90,866,000 +$8,736,000 +11% 30 Sep 2020 10-Q 09 Nov 2020 2021 Q1
Q2 2020 $93,020,000 30 Jun 2020 10-K 26 Aug 2020 2020 FY
Q1 2020 $79,035,000 31 Mar 2020 10-Q 11 May 2020 2020 Q3
Q4 2019 $81,091,000 31 Dec 2019 10-Q 06 Feb 2020 2020 Q2
Q3 2019 $82,130,000 30 Sep 2019 10-Q 06 Nov 2019 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.